Latest news
Show 1482: Are Your Kidneys in Trouble? Two Tests Could Tell You - The People's PharmacyThe People's Pharmacy · Sat, 08 Aug 2026 17:04:43 GMTLCT Gains Ground in EGFR-Mutated NSCLC - OncLiveOncLive · Fri, 07 Aug 2026 14:05:45 GMTTreatment Strategies Following Progression in EGFR-Mutant NSCLC - OncLiveOncLive · Fri, 07 Aug 2026 01:41:15 GMTRisk Stratification and Treatment Selection in EGFR-Mutant NSCLC - OncLiveOncLive · Thu, 06 Aug 2026 19:45:26 GMTAcupuncture-associated gastric mucosal repair and the EGF–EGFR-related signaling network: evidence, limitations, and prospects - FrontiersFrontiers · Thu, 06 Aug 2026 07:00:00 GMTEGFR Amplification in EGFR-Mutated NSCLC: Critical Risk Marker - OncodailyOncodaily · Wed, 05 Aug 2026 14:17:49 GMTOtsuka Unveils Unprecedented Phase 3 VISIONARY Two-Year eGFR Results Demonstrating VOYXACT® (sibeprenlimab-szsi) Stabilizes Kidney Function Decline to Baseline Physiologic Rate, Fundamentally Altering Disease Progression in IgA Nephropathy - Business WireBusiness Wire · Mon, 03 Aug 2026 21:00:00 GMTIndividualizing Frontline Treatment Decisions in EGFR-Mutant NSCLC - OncLiveOncLive · Fri, 31 Jul 2026 07:07:10 GMT